Safety and Ethical Considerations
As DNA nanobot therapies move closer to reality, important safety and ethical questions arise. Ensuring these nanobots do not trigger unintended effects or persist in the body longer than intended is critical. Regulatory agencies will require rigorous trials and transparent data. Patient consent and understanding of long-term risks must be prioritized. Open discussion about the ethical use of programmable biological machines will be essential as this technology enters clinical practice.